Business Wire

Scandinavian Airlines Brings on Neustar® to Measure Marketing’s Impact on Key Business Drivers

Del

Neustar®, Inc., a trusted, neutral provider of real-time information services, today announced that Scandinavian Airlines, has selected Neustar’s advanced marketing analytics solution to understand the impact of its marketing contributions on sales. Scandinavian Airlines sought a partner like Neustar to drive greater impact of its marketing activities and to pinpoint more efficient marketing investments. As an authoritative, neutral provider connecting analytics to business growth, Neustar MarketShare® will provide Scandinavian Airlines with the data-driven insights to guide day-to-day marketing planning and buying decisions.

Scandinavian Airlines selected Neustar for its industry-leading Marketing Mix Modeling (MMM) approach as it allows the airline to examine key sales channels and essential regions to determine the optimal mix for driving bookings and other business outcomes. In addition, to give Scandinavian Airlines a holistic view across their media activities, Neustar MarketShare models will capture various impact drivers – media, non-media and exogenous (e.g. economy, competition, seasonality, etc.) – to help the airline run scenarios to measure and forecast the impact of changes in any of the drivers. Neustar’s first-class account management team with extensive analytical, strategic and tactical media experience will also assist Scandinavian Airlines with the development of advanced analytics models that value the return on investment (ROI) of marketing channels and tactics.

“Understanding the key drivers on our business and ensuring we allocate marketing spend where we see the highest returns, whilst mitigating any revenue risks, are essential to SAS,” said Didrik Fjeldstad, Vice President, Brand and Marketing, SAS. “Building a robust analytics and ROMI measurement practice is of utmost importance to us as it ensures we optimize our media spend whilst mitigating any risk to the business. Working with a partner like Neustar will allow us to make much faster and smarter decisions about our marketing investments and increase profitability.”

Scandinavian Airlines is taking a laser-focused approach to building a standard framework for measuring the return on marketing investment (ROMI) across its three major markets – Denmark, Norway and Sweden. By building a robust ROMI culture across its organization and geographic footprint, Scandinavian Airlines will be able to allocate marketing expenditures more efficiently and shift spend to high performing channels, markets and activities. In doing so, it is bringing the marketing intelligence decisions in-house and with its appointed media agencies and platforms, creating a more transparent media measurement and attribution process. For example, Scandinavian Airlines can now access the Neustar MarketShare always-on measurement and optimization platform to be predictive in how they most effectively and efficiently plan and deploy media.

“Now more than ever marketers want to distinguish between marketing activities that are driving business value and those that don’t,” said Luis Chaves, Managing Director, Marketing Solutions EMEA, Neustar. “Marketers who take a holistic and unified approach to marketing analytics and measurement will undoubtedly outsmart the competition. We are thrilled to be working with such a highly regarded and forward-thinking European airline to help them make better and faster decisions.”

The Neustar MarketShare Marketing Planning and Allocation solution offers advertisers a guide to budgeting and planning decisions, as well as trade-off scenarios for allocations – predictively – across products, markets, segments and channels. It takes into consideration both the offline marketing tactics and the non-media drivers (e.g. weather, economic indicators, competitor actions, etc.) in order to help clients examine the true value of their marketing performance. Marketers can build an optimal marketing plan to boost their revenue and more accurately allocate their marketing resources, course correcting to improve ROMI. The Neustar MarketShare next-generation tool for unified marketing impact analytics keeps pace with the rapidly changing marketing landscape to assure that marketers are maximizing their business results and proving marketing’s contribution to revenue at every opportunity.

About Neustar

Neustar, Inc. is a leading global information services provider driving the connected world forward with trusted, holistic identity resolution. As the only company capable of understanding who is on the other end of every interaction, Neustar is trusted by the world’s great brands to grow and guard their businesses with the most complete knowledge of how to connect people, places and things. The combination of Neustar’s unique, accurate, and real-time identity system and our cloud-based workflow solutions empower our clients to make actionable, precise and valuable decisions across marketing, risk, IT/security, network and operations departments. More information is available at https://www.home.neustar.

About Scandinavian Airlines (SAS)

SAS carries more than 30 million passengers annually and is Scandinavia's leading airline with close to 800 daily flights on 272 routes to 123 destinations in Scandinavia, Europe, USA and Asia. SAS is a member of Star Alliance™ and can together with our partner airlines offer more than 18,400 daily flights to 1,300 destinations around the world in over 191 countries. For more information, visit www.flysas.com.

Contact information

Neustar Media Contact
Hannah Lock
Hotwire Global (on behalf of Neustar)
NeustarUK@hotwireglobal.com
+44 07393 465 537

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Pierre Fabre & Array BioPharma Announce a 62% Observed OS at One Year from the Phase 3 BEACON CRC Safety Lead-In of the Combination of Encorafenib, Binimetinib and Cetuximab in BRAF-Mutant CRC at the ESMO GI Congress23.6.2018 11:00Pressemelding

Not intended for UK- and US-based media Pierre Fabre and its partner Array BioPharma Inc. today announced updated safety and efficacy results, including OS, from the safety lead-in of the Phase 3 BEACON CRC trial evaluating the triplet combination of encorafenib, a BRAF inhibitor, binimetinib, a MEK inhibitor and cetuximab, an anti-EGFR antibody, in patients with BRAF V600E -mutant metastatic colorectal cancer (CRC). The results showed that, at the time of analysis, the OS data were fully mature through 12.6 months and that the median OS had not yet been reached. The one-year overall survival rate for this cohort was 62%. These data were presented in an oral presentation on Saturday, June 23, at the ESMO 20th World Congress on Gastrointestinal Cancer in Barcelona, Spain. The median progression-free survival (mPFS) for patients treated with the triplet was 8 months [95% CI 5.6-9.3] and is similar between patients receiving one prior line of therapy and patients receiving two prior lines

Compelling Data for LONSURF® (trifluridine/tipiracil) in Metastatic Colorectal Cancer Presented at ESMO’s World Congress on Gastrointestinal Cancer by Servier and Taiho23.6.2018 08:10Pressemelding

Servier and Taiho Pharmaceutical Co., Ltd. today announced that the TASCO-1 trial demonstrated promising results for LONSURF® (trifluridine/tipiracil) in combination with bevacizumab in patients with previously untreated metastatic colorectal cancer (mCRC) who are not suitable for intensive treatment, with a median progression-free survival (PFS) of 9.2 months (ranging from 7.6 to 11.5 months). A second non-comparative arm in the trial, evaluated the outcome of patients treated with the current standard of care of capecitabine in combination with bevacizumab. The median PFS of this arm was 7.8 months (ranging from 5.5 to 10.1 months). “Colorectal cancer is the third most common cancer in the world. While there has been some progress in treatment, there are still few options for patients with metastatic disease who are not suitable for intensive treatment,” said Professor Eric Van Cutsem, Head of Digestive Oncology at the University of Leuven, Belgium. “These compelling results suggest

Softomotive and Accelerate RPA Partner to Help Enterprises Achieve Faster Time to Value from RPA22.6.2018 15:13Pressemelding

Softomotive, a world–class Robotic Process Automation (RPA) technology provider offering best time to value and affordability for all sizes and types of enterprises, is pleased to announce a strategic partnership with AccelerateRPA, a high calibre professional services provider of trained and certified RPA Consultants within Robotic Process Automation. This partnership means that customers and end users of Softomotive’s software, will have additional knowledgeable and professional guidance available to help achieve significant value quickly from their investment in RPA. Companies who are looking to implement Softomotive’s RPA product suite (WinAutomation and ProcessRobot software) will now have direct access to AccelerateRPA’s highly skilled consultants and Developers. Further, AccelerateRPA has also become a licensed reseller of Softomotive’s products, offering customers a single point of contact for delivering both RPA software and services. Ashley Hudson, Director of AccelerateRPA,

Ascend Performance Materials Announces Price Increase for Intermediate Materials22.6.2018 14:00Pressemelding

Ascend Performance Materials announced today a price increase for its intermediate materials. The price increase will take effect globally on July 1, 2018, and includes the following terms: Material Price Increase Terms Hexamethylene diamine (HMD) $0.17/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Acrylonitrile (AN) $0.20/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Customers should contact their local sales representative for additional information. About Ascend Performance Materials Ascend Performance Materials is a global premium provider of high-quality plastics, fibers and chemicals and is the world’s largest integrated producer of PA66 resin. Headquartered in Houston, Texas, Ascend has eight global locations, including five fully-integrated manufacturing facilities located in the southeastern United States, all dedicated to the innovation and safe production of nylon 6,6. With

Different Countries, Different Customs: Get Ready for the Motorbike Holidays with Moto-tyres.co.uk22.6.2018 13:41Pressemelding

Pack your bags, close the boot and get away on holiday? When you start your holidays on a motorcycle, you usually have to consider a few things more when getting ready for your trip. The right preparation is therefore a must. So that nothing stands in the way of a smooth journey, Moto-tyres.co.uk has put together some tips for your next trip. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180622005345/en/ Different countries, different customs: get ready for the motorbike holidays with Moto-tyres.co.uk (Photo: Business Wire) Whether a weekend trip or extended adventure, it all depends on the right equipment. Functional clothing, protectors and rain protection are a must on long trips. Wearing a suitable motorcycle helmet is a legal requirement almost everywhere. However, there are also very different rules and regulations for motorbike equipment and accessories depending on the destination, and you should familiarise yoursel

Boehringer Ingelheim bolsters biologics research and development with 230 million euro investment in new development center22.6.2018 12:00Pressemelding

Today Boehringer Ingelheim announced a 230 million euro investment into a new Biologicals Development Center (BDC) at the company’s Research and Development site in Biberach, Germany during the foundation stone laying for the new center. “The BDC is another key building block supporting the company’s long-term strategy for increasing the pipeline’s share of biologicals. This is particularly driven by two of our core areas, immune oncology and immunology,” says Dr. Fridtjof Traulsen, Corporate Senior Vice President Development at Boehringer Ingelheim. “The share of new biological entities in Boehringer Ingelheim’s research pipeline has been consistently increasing over the past few years and has now reached forty percent.” The BDC will help to maximize synergies by integrating biologicals analytical and process development as well as manufacturing for clinical studies into one seamless unit, while at the same time increasing development capacity. Following a staggered launch beginning i